3 | SEC Filings Hub

Filing metadata

Accession number: 0000905148-21-000054
Form type: Form 3
Filer: EyePoint Pharmaceuticals, Inc.
CIK: CIK 1314102
Filed: Jan 14, 2021
Reporting period: Dec 31, 2020
Description: Initial ownership

Documents

0000905148-21-000054-index.htm

Complete submission

0000905148-21-000054.txt

directory listing

Filed by

EyePoint Pharmaceuticals, Inc.